WATERTOWN, Mass.--(BUSINESS WIRE)--May 15, 2006--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC - News), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that Frederick Schmid, DVM, MBA, has joined the Company as Senior Vice President, Commercial Operations and Business Development. Dr. Schmid will have responsibility for overseeing business development, marketing, and product commercialization at Panacos and will report to Panacos’ President and CEO, Dr. Samuel K. Ackerman.
